Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
CIB1 Biologics Sequence Review Report 2026: Calcium and integrin-binding protein 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CIB1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
AR Biologics Sequence Review Report 2026: Androgen receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of AR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
APOBR Biologics Sequence Review Report 2026: Apolipoprotein B receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of APOBR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
APELA Biologics Sequence Review Report 2026: Apelin receptor early endogenous ligand Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of APELA sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRL3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRL3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRG6 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G6 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRG6 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRG2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRG2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRF3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRF3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRF1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRF1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRD2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor D2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRD2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRA3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor A3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRA3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRA2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor A2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRA2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
888
889
890
891
892
>>
2926
>